Healio12d
25.4% of patients with bronchiectasis had symptoms for more than 10 years before diagnosis
This study cohort was made up of 71.3% U.K. patients with bronchiectasis. Referral to pulmonary rehabilitation was presented to 19.6% of patients. Prior to being diagnosed with bronchiectasis ...
pharmaphorum3d
FDA starts review of first bronchiectasis drug candidate
The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...